Cargando…
IGF-1R targeting in cancer – does sub-cellular localization matter?
The insulin-like growth factor receptor (IGF-1R) was among the most intensively pursued kinase targets in oncology. However, even after a slew of small-molecule and antibody therapeutics reached clinical trials for a range of solid tumors, the initial promise remains unfulfilled. Mechanisms of resis...
Autores principales: | Soni, Upendra K., Jenny, Liam, Hegde, Rashmi S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588251/ https://www.ncbi.nlm.nih.gov/pubmed/37858153 http://dx.doi.org/10.1186/s13046-023-02850-7 |
Ejemplares similares
-
Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
por: Soni, Upendra Kumar, et al.
Publicado: (2023) -
The Eyes Absent proteins in development and in developmental disorders
por: Soni, Upendra Kumar, et al.
Publicado: (2021) -
Does Reduced IGF-1R Signaling in Igf1r
(+/−) Mice Alter Aging?
por: Bokov, Alex F., et al.
Publicado: (2011) -
Sub-Cellular Localization of Metalloproteinases in Megakaryocytes
por: Malara, Alessandro, et al.
Publicado: (2018) -
Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets
por: Zhang, Yinqi, et al.
Publicado: (2021)